Search results
Results from the WOW.Com Content Network
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
For more information about Science 37’s enrollment solutions and its role in delivering qualified participants to clinical research studies such as the GSK PBC trial, please visit www.science37.com. About GSK. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies transferring their HIV assets to the new company. [1] In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. [2]
Stiefel was acquired by GlaxoSmithKline in July 2009 to create a new specialist dermatology business. As part of the acquisition, Stiefel Laboratories is now branded "Stiefel, a GSK company" in advertising. [11] Stiefel launched MaxClarity [12] and received FDA approval of two Rx products in the United States, [13] Sorilux Foam and Veltin Gel ...
According to GSK, this new investment will be utilized to bring state-of-the-art drug substance manufacturing and additional drug product capabilities to their Marietta facility at 325 North ...
Akt promotes G1-S phase cell cycle progression by phosphorylating and inactivating glycogen synthase kinase 3 (GSK-3) at Ser9. This prevents the phosphorylation and degradation of cyclin D1 . [ 31 ] Therefore, Akt promotes G1 phase progression in a positive feedback loop.
GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002. [4] In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately US$36.5 million. [5]